Christophe Berthoux, MD

Superior Science and Risk-Sharing Business Models Accelerating Drug Development with AI and Smart Imaging Imaging Protocol Design and Optimal Endpoint Selection Cloud Platform DYNAMIKA for Central Data Management and Review
archimed-christophe-2_3

Christophe Berthoux, MD

Chairman
Biotech and Pharma Drug Development Strategy
Christophe is IAG's Chairman and an Operating Parter in ArchiMed, independent investment firm specialized in the Healthcare industries. Prior to this, he has spent his 20+ year career within the Clinical Research industry, and brings extensive expertise and knowdledge of this sector. Christophe was CEO of UK based Synexus, a leading global SMO and European CEO of Citoxlab Christophe Berthoux, is a doctor in veterinary medicine and holds an MBA from Purdue University, Indiana (US).